MF
TBPH icon

Magnetar Financial’s Theravance Biopharma TBPH Stock Holding History

Magnetar Financial’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Sell
11,972
-4,531
-27% -$75K ﹤0.01% 938
2026
Q1 		$268K Sell
16,503
-474
-3% -$8.39K ﹤0.01% 782
2025
Q4 		$318K Buy
+16,977
New +$282K ﹤0.01% 669
2025
Q2 		– Sell
-26,739
Closed -$239K – 1133
2025
Q1 		$239K Sell
26,739
-772
-3% -$7.18K ﹤0.01% 621
2024
Q4 		$259K Buy
27,511
+15,328
+126% +$139K 0.01% 507
2024
Q3 		$98.2K Buy
+12,183
New +$106K ﹤0.01% 493

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Magnetar Financial's TBPH Position: Q2 2026 in Review

Magnetar Financial reduced its Theravance Biopharma (TBPH) stake by 27% in Q2 2026, selling an estimated $75K and leaving 11,972 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Magnetar Financial first reported a position in TBPH in Q3 2024 and has held it in 6 quarters since. The position peaked at $318K in Q4 2025. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Magnetar Financial held 11,972 shares of Theravance Biopharma worth $204K as of Q2 2026.
  • Magnetar Financial sold 4,531 Theravance Biopharma shares in Q2 2026, an estimated $75K.
  • Theravance Biopharma made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #938 holding.
  • Magnetar Financial first reported a position in Theravance Biopharma in Q3 2024 and has held it in 6 quarters since.
  • Magnetar Financial's Theravance Biopharma position peaked at $318K in Q4 2025.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.